Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Moustafa T Gabr

Showing results (81-90 of 107) with videos related to

Pageof 11
Sort By:
Biorxiv : the Preprint Server for Biology|August 16, 2024
Discovery of ICOS-targeted small molecules using affinity selection mass spectrometry screeningLongfei Zhang, Laura Calvo-Barreiro, Victor de Sousa Batista, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|December 3, 2025
As48, a first-in-class dual-function TREM2 modulator: Receptor activation and shedding inhibitionSungwoo Cho, Farida El Gaamouch, Saurabh Upadhyay, et al.
Biorxiv : the Preprint Server for Biology|July 16, 2025
Discovery of an Achiral Small Molecule TREM2 Agonist with Improved Pharmacokinetic Profile and Validated Target EngagementShaoren Yuan, Farida El Gaamouch, Sungwoo Cho, et al.
Biorxiv : the Preprint Server for Biology|September 5, 2025
As48, a First-in-Class Dual-Function TREM2 Modulator: Receptor Activation and Shedding InhibitionSungwoo Cho, Farida El Gaamouch, Saurabh Upadhyay, et al.
ACS Medicinal Chemistry Letters|August 20, 2025
Discovery of a Small Molecule TREM2 Agonist with Improved In Vitro Pharmacokinetic Profile and Validated Target EngagementShaoren Yuan, Farida El Gaamouch, Sungwoo Cho, et al.
Trends in Pharmacological Sciences|July 19, 2025
TREM2 and LAG-3 in cancer and Alzheimer's disease immunotherapyShaoren Yuan, Natalie S Fuchs, Somaya A Abdel-Rahman, et al.
ACS Medicinal Chemistry Letters|November 20, 2024
From Virtual Screens to Cellular Target Engagement: New Small Molecule Ligands for the Immune Checkpoint LAG-3Natalie Fuchs, Laura Calvo-Barreiro, Valerij Talagayev, et al.
EXCLI Journal|September 30, 2015
EGFR tyrosine kinase targeted compounds: in vitro antitumor activity and molecular modeling studies of new benzothiazole and pyrimido[2,1-b]benzothiazole derivativesMoustafa T Gabr, Nadia S El-Gohary, Eman R El-Bendary, et al.
RSC Chemical Biology|June 10, 2026
Peptides as programmable molecular scaffolds: from chemical synthesis and engineering to translational medicineShaoren Yuan, Baljit Kaur, Natalie S Fuchs, et al.
Journal of Medicinal Chemistry|August 20, 2025
Discovery and Optimization of LAG-3-Targeted Small Molecules via DNA-Encoded Chemical Library (DEL) Screening for Cancer ImmunotherapySomaya A Abdel-Rahman, Laura Calvo-Barreiro, Nelson García Vázquez, et al.
Pageof 11

Showing results (81-90 of 107) with videos related to

Sort By:
Pageof 11
Biorxiv : the Preprint Server for Biology|August 16, 2024
Discovery of ICOS-targeted small molecules using affinity selection mass spectrometry screeningLongfei Zhang, Laura Calvo-Barreiro, Victor de Sousa Batista, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|December 3, 2025
As48, a first-in-class dual-function TREM2 modulator: Receptor activation and shedding inhibitionSungwoo Cho, Farida El Gaamouch, Saurabh Upadhyay, et al.
Biorxiv : the Preprint Server for Biology|July 16, 2025
Discovery of an Achiral Small Molecule TREM2 Agonist with Improved Pharmacokinetic Profile and Validated Target EngagementShaoren Yuan, Farida El Gaamouch, Sungwoo Cho, et al.
Biorxiv : the Preprint Server for Biology|September 5, 2025
As48, a First-in-Class Dual-Function TREM2 Modulator: Receptor Activation and Shedding InhibitionSungwoo Cho, Farida El Gaamouch, Saurabh Upadhyay, et al.
ACS Medicinal Chemistry Letters|August 20, 2025
Discovery of a Small Molecule TREM2 Agonist with Improved In Vitro Pharmacokinetic Profile and Validated Target EngagementShaoren Yuan, Farida El Gaamouch, Sungwoo Cho, et al.
Trends in Pharmacological Sciences|July 19, 2025
TREM2 and LAG-3 in cancer and Alzheimer's disease immunotherapyShaoren Yuan, Natalie S Fuchs, Somaya A Abdel-Rahman, et al.
ACS Medicinal Chemistry Letters|November 20, 2024
From Virtual Screens to Cellular Target Engagement: New Small Molecule Ligands for the Immune Checkpoint LAG-3Natalie Fuchs, Laura Calvo-Barreiro, Valerij Talagayev, et al.
EXCLI Journal|September 30, 2015
EGFR tyrosine kinase targeted compounds: in vitro antitumor activity and molecular modeling studies of new benzothiazole and pyrimido[2,1-b]benzothiazole derivativesMoustafa T Gabr, Nadia S El-Gohary, Eman R El-Bendary, et al.
RSC Chemical Biology|June 10, 2026
Peptides as programmable molecular scaffolds: from chemical synthesis and engineering to translational medicineShaoren Yuan, Baljit Kaur, Natalie S Fuchs, et al.
Journal of Medicinal Chemistry|August 20, 2025
Discovery and Optimization of LAG-3-Targeted Small Molecules via DNA-Encoded Chemical Library (DEL) Screening for Cancer ImmunotherapySomaya A Abdel-Rahman, Laura Calvo-Barreiro, Nelson García Vázquez, et al.
Pageof 11